As retinal and ocular diseases continue to surge worldwide, the need for safer, longer-lasting, and more patient-friendly treatments has never been more urgent. At the center of this innovation race lies one critical challenge: delivery.
From sustained-release formulations and suprachoroidal administration to novel device–drug combinations, the ophthalmic field is witnessing a wave of breakthroughs designed to improve durability, targeting, and adherence. These advances are transforming how – and where – ocular therapies deliver impact.
This eBook dives into the latest science, technologies, and translational strategies reshaping ophthalmic drug delivery, spotlighting insights from the 4th Ophthalmic Drug Delivery Summit.
Inside, you’ll discover:
- How sustained-release and local delivery platforms are improving long-term efficacy
- Advances in device–drug combinations for precise ocular targeting
- Best practices for translating durable formulations into clinical success
- Expert perspectives from 80+ leaders shaping the future of eye care innovation
Access your free copy to explore how ophthalmic innovators are redefining patient-centric delivery for the next generation of transformative eye therapies.
About Hanson Wade Group - 4th Ophthalmic Drug Delivery Summit
Innovating Patient-Centric, Longer-Lasting Delivery to Specific Ocular Targets to Strengthen Adherence to Transformative Ophthalmic Therapies with Enhanced Durability & Formulation
As the global burden of retinal and ocular diseases continues to rise, the race to develop safer, longer-lasting, and less invasive treatments is accelerating. At the heart of this challenge lies drug delivery. The 4th Ophthalmic Drug Delivery Summit arrives at a pivotal moment, bringing together over 80 leading experts from the pharmaceutical and biotech industries to tackle the toughest delivery hurdles limiting the impact of cutting-edge therapeutics.
With industry momentum building around sustained-release technologies, suprachoroidal administration, and innovative device-drug combinations, this summit is your gateway to the breakthroughs redefining ocular treatment. From translating long-acting formulations into clinical success to navigating regulatory complexities early, this is the only event dedicated to transforming how and where ophthalmic therapies work - making it a must-attend for anyone shaping the future of eye care.
Download the Event Guide
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices, and treatments.